Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-17 Sale |
2025-01-17 9:17 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
5,584 | $0.5808 | $3,243 | 7,510 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 4:17 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
22,195 | $0.58211 | $12,920 | 13,756 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 5:31 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
20,563 | $0.68601 | $14,106 | 19,257 (Direct) |
View |
| 2024-01-11 Sale |
2024-01-12 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
11,808 | $0.84819 | $10,015 | 11,841 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-17 9:16 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,159 | $1.858 | $4,011 | 3,491 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-12 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
11,292 | $1.7199 | $19,421 | 12,191 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-04 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
876 | $1.694 | $1,484 | 1,361 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,121 | $3.1918 | $6,770 | 3,529 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
4,624 | $3.5544 | $16,435 | 1,383 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 9:05 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
849 | $4.0642 | $3,451 | 1,388 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-19 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,111 | $5.6695 | $11,968 | 3,539 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-12 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
841 | $6.1522 | $5,174 | 1,396 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
845 | $5.3279 | $4,502 | 1,392 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-20 Option Award |
2025-02-20 5:31 pm |
N/A 2035-02-20 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,686,728 | $0 | 2,686,728 (Direct) |
View |
| 2024-01-15 Option Award |
2024-01-17 5:01 pm |
N/A 2034-01-15 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
3,109,848 | $0 | 3,109,848 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:03 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
1,914,672 | $0 | 1,914,672 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:02 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,581,968 | $0 | 2,581,968 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:02 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |